Platelet-derived endothelial cell growth factor (PD-ECGF) is up-regulated in human hepatocellular carcinoma (HCC) and the corresponding hepatitis liver

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1521-1526

  Morinaga, Soichiro ^a,d   Yamamoto, Yuji ^a   Noguchi, Yoshikazu ^a   Imada, Toshio ^b   Rino, Yasushi ^b   Akaike, Makoto ^c   Sugimasa, Yukio ^c   Takemiya, Shoji ^c   Takanashi, Yoshinori ^b  

^a Yokohama City Kowan Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

^d Yokohama Kowan Hospital   (Japan)

Author keywords

Angiogenesis; Hepatitis; Hepatocellular carcinoma; Platelet derived endothelial cell growth factor

Indexed keywords

ALANINE AMINOTRANSFERASE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; TISSUE EXTRACT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS; HISTOLOGY; HUMAN; LIVER; LIVER CELL CARCINOMA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TISSUE NECROSIS; UPREGULATION;

ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; HEPATITIS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; THYMIDINE PHOSPHORYLASE; UP-REGULATION;

EID: 0141651577     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182-1186.
2. Weidner N: Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147:9-19.
3. Fox SB, Gatter KC, Harris AL: Tumor angiogenesis. J Pathol 1996; 179:232-237.
4. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y: Angiogenic activity of enzymes. Nature 1994; 368:198.
5. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Yamada Y: Angiogenic factor. Nature 1992; 356:668.
6. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaki F, Risau WW, Heldin C-H: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989; 338:557-562.
7. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T, Aikou T: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996; 87:288-295.
8. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y, Sowa M: Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996; 73:884-888.
9. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996; 88:1110-1117.
10. Mizutani Y, Okada Y, Yoshida O: Expression of platelet derived endothelial cell growth factor in bladder carcinoma. Cancer 1997; 79:1190-1194.
11. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T: Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers. Br J Cancer 1999; 79:1249-1254.
12. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC, Harris AL: Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 1997; 75:477-481.
13. Takebayashi Y, Natsugoe S, Baba M, Akiba S, Fukumoto T, Miyadera K, Yamada Y, Takao S, Akiyama S, Aikou T: Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer 1999; 85:282-289.
14. Jin-no K, Tanimizu M, Hyodo I, Nishikawa I, Hosokawa Y, Endo H, Doi T, Mandai K, Ishitsuka H: Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients. Cancer 1998; 82:1260-1267.
15. Zhou J, Tang Z, Fan J, Wu Z, Li X, Liu Y, Liu E, Sun H, Ye S: Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. J Cancer Res Clin Oncol 2000; 126:57-61.
16. Yamamoto A, Dhar DK, El-Assal ON, Igarashi M, Tabara H, Nagasue N: Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma. J Hepatol 1998; 29:290-299.
17. Shimada M, Hasegawa H, Rikimaru T, Gion T, Hamatsu T, Tanashita Y, Shirabe K, Sugimachi K: The significance of thymidine phosphorylase activity in hepatocellular carcinoma and chronic diseased livers: a special reference to liver fibrosis and multicentric tumor occurrence. Cancer Lett 2000; 148:165-172.
18. Arii S, Okamoto E, Imamura M, Liver cancer study group of Japan: Registries in Japan: current status of hepatocellular carcinoma in Japan. Semin Surg Oncol 1996; 12:204-211.
19. Nishida M, Hino A, Kazushige M, Matsumoto T, Yoshikubo T, Ishitsuka H: Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996; 19:1407-1411.
20. Himeno H, Enzan H, Saibara T: Hitherto unrecognized arterioles within hepatocellular carcinoma. J Pathol 1994; 174:217-222.
21. Morinaga S, Imada T, Shimizu A, Akaike M, Sugimasa Y, Takemiya S, Takanashi Y: Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry. Hepatogastroenterology 2001; 48:224-228.
22. Desmet UJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-1520.
23. Yoshimura Y, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S: Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochem Biophys Acta 1990; 1034:107-113.
24. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995; 176:183-190.
25. Fox SB, Weatwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, GatterKC, Harris AL: The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 1996; 73:275-280.
26. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR, Ellis LM: Platelet-derived endothelial cell growth factor PD-ECGF in human colon cancer angiogenesis; role of infiltrating cells. J Natl Cancer Inst 1996; 88:1146-1151.
27. Lee AH, Dublin EA, Bobrow LG: Angiogenesis and expression of thymidine phosphorylase in ductal carcinoma in situ of the breast. J Pathol 1999; 187:285-290.
28. Tanigawa N, Lu Caide, Mitsui T, Miura S: Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 1997; 26:1216-1223.
29. Haratake J, Scheuer PJ: An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma. Cancer 1990; 65:1985-1993.
30. Tarao K, Rino Y, Ohkawa S, Shimizu A, Tamai S, Miyakawa K, Aoki H, Imada T, Shindo K, Okamoto N, Totsuka S: Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus associated cirrhosis. Cancer 1999; 86:589-595.
31. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saito S, Kobayashi M, Kumada H: The long term efficacy of glycyrrhzin in chronic hepatitis patients. Cancer 1997; 79:1494-1500.